{
  "ticker": "LLY",
  "target_date": "2025-03-17",
  "actual_date": "2025-03-17",
  "collected_at": "2025-12-08T11:31:32.077158",
  "price": {
    "open": 812.3,
    "high": 824.28,
    "low": 809.93,
    "close": 820.064697265625,
    "volume": 2546600,
    "change_1d_pct": 1.39,
    "change_7d_pct": -9.64,
    "change_30d_pct": 1.86
  },
  "technicals": {
    "rsi_14": 33.69,
    "sma_20": 868.2,
    "sma_50": 825.9,
    "macd": -5.825,
    "macd_signal": 7.615,
    "macd_histogram": -13.439,
    "bb_upper": 951.79,
    "bb_lower": 784.61,
    "price_vs_sma20_pct": -5.54,
    "price_vs_sma50_pct": -0.71,
    "volume_ratio": 0.7
  },
  "fundamentals": {
    "market_cap": 889329942528,
    "pe_ratio": 48.606075,
    "forward_pe": 43.77979,
    "price_to_book": 37.35128,
    "price_to_sales": 14.966896,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.79,
    "pct_from_52w_low": 59.04
  },
  "macro": {
    "spy": {
      "price": 562.22,
      "change_1d_pct": 0.77,
      "change_7d_pct": -1.52
    },
    "vix": {
      "level": 20.51,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.31
    },
    "dollar_index": {
      "level": 103.37
    },
    "gold": {
      "price": 3000.0
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Why Organon Is A Top Pick For Income Investors",
      "source": "SeekingAlpha",
      "datetime": 1742252303,
      "summary": "In mid-Feb., Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for income-oriented investors.",
      "url": "https://finnhub.io/api/news?id=697fea97f771736843602e4ccd567ee09566458d477be611dbdde99159b46b96"
    },
    {
      "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "source": "MarketWatch",
      "datetime": 1742229060,
      "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=7eb45cacc93b9bd6acdb1f5797ab05484657d4f6fcdddeeb14c3e79f0d4cabd1"
    },
    {
      "headline": "Eli Lilly: A Safe Harbor Amid Market Volatility",
      "source": "SeekingAlpha",
      "datetime": 1742223484,
      "summary": "Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here to read why LLY is a Strong Buy.",
      "url": "https://finnhub.io/api/news?id=4215e8f31df31fc520097fb916458201b06cc66a4fe4fcc11ce71808cd59370a"
    },
    {
      "headline": "We Could Have A Clear Shot To 6,000, But Be Proactive",
      "source": "SeekingAlpha",
      "datetime": 1742156053,
      "summary": "A potential rally to 6,000 is possible if retail sales are positive and the FOMC Meeting is dovish. Read why investors should focus on Fab 5.",
      "url": "https://finnhub.io/api/news?id=b5f3213ea2e6b78a475e250056dd5914c14e4a6af8b101c64d67240d28c31552"
    },
    {
      "headline": "Jim Cramer Says: \u201cKeep an Eye on Eli Lilly and Company (LLY)\u201d",
      "source": "Yahoo",
      "datetime": 1742136889,
      "summary": "We recently published a list of Jim Cramer Discusses These 10 Stocks & Says Trump Should Carry A Howitzer And Be Soft. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. In a fresh appearance on CNBC\u2019s Squawk ",
      "url": "https://finnhub.io/api/news?id=c6a91915ebfc1665a6c8f63a85299d076da31f41c12473ba1288d6a90b86b50e"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-13",
      "description": "xslF345X05/wk-form4_1741897046.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000091/xslF345X05/wk-form4_1741897046.xml"
    },
    {
      "form": "4",
      "date": "2025-03-04",
      "description": "xslF345X05/form4-03042025_040301.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925006450/xslF345X05/form4-03042025_040301.xml"
    },
    {
      "form": "4",
      "date": "2025-03-03",
      "description": "xslF345X05/wk-form4_1741038785.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000083/xslF345X05/wk-form4_1741038785.xml"
    },
    {
      "form": "4",
      "date": "2025-03-03",
      "description": "xslF345X05/wk-form4_1741038712.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000081/xslF345X05/wk-form4_1741038712.xml"
    },
    {
      "form": "4",
      "date": "2025-02-26",
      "description": "xslF345X05/form4-02262025_040201.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005670/xslF345X05/form4-02262025_040201.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}